Merger Notification - Announcement according to § 10 Cartel Act
Gilead Sciences, Inc.; MYR GmbH
BWB/Z-5198
On 11.01.2021 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Gilead Sciences Inc. (California / USA) intends to acquire all shares in and sole control over MYR GmbH (Bad Homburg / Germany). Gilead is listed on NASDAQ. Shareholdings in Gilead are widely dispersed. None of Gilead’s shareholders holds 25% or more of the shares in or exercises control over Gilead. The proposed concentration concerns the treatment of chronic Hepatitis D virus infections.
Affected industry: Pharmaceutical products (ÖNACE-Code: C 21)"
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 08.02.2021.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 09.02.2021 .